Longeveron logo

Longeveron share price today

(LGVN)

Longeveron share price is $1.75 & ₹149.69 as on 30 Dec 2024, 20.25 hrs IST

$1.75

-0.09

(-4.89%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Longeveron share price in Dollar and Rupees. Guide to invest in Longeveron from India. Also see the sentimental analysis on Indian investors investing in Longeveron. Get details on the Indian mutual funds that are investing in Longeveron. Get Analyst recommendations and forecasts along with all the Longeveron's financials.

Longeveron share price movements

  • Today's Low: $1.71
    Today's High: $1.84

    Day's Volatility :7.07%

  • 52 Weeks Low: $0.77
    52 Weeks High: $14.30

    52 Weeks Volatility :94.61%

Longeveron Returns

PeriodLongeveron IncIndex (Russel 2000)
3 Months
-9.79%
0.0%
6 Months
11.46%
0.0%
1 Year
-86.74%
0.0%
3 Years
-98.55%
-21.3%

Longeveron Key Statistics

in dollars & INR

Previous Close
$1.75
Open
$1.8
Today's High
$1.7319
Today's Low
$1.67
Market Capitalization
$27.3M
Today's Volume
$297.0K
52 Week High
$14.3
52 Week Low
$0.7707
Revenue TTM
$1.2M
EBITDA
$-17.2M
Earnings Per Share (EPS)
$-5.62
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-142.16%

How to invest in Longeveron from India?

It is very easy for Indian residents to invest directly in Longeveron from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Longeveron stock in both Indian Rupees (INR) and US Dollars (USD). Search for Longeveron or LGVN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Longeveron or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Longeveron shares which would translate to 0.489 fractional shares of Longeveron as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Longeveron, in just a few clicks!

Returns in Longeveron for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Longeveron investment value today

Current value as on today

₹16,052

Returns

₹83,948

(-83.95%)

Returns from Longeveron Stock

₹86,742 (-86.74%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Longeveron

11%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Longeveron on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 11% more investors are searching Longeveron in the last 30 days versus the previous period.

Global Institutional Holdings in Longeveron

  • Geode Capital Management, LLC

    0.87%

  • Vanguard Group Inc

    0.30%

  • Capital Investment Advisory Services, LLC

    0.18%

  • State Street Corp

    0.10%

  • Creative Planning Inc

    0.08%

  • BlackRock Inc

    0.07%

Analyst Recommendation on Longeveron

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Longeveron(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Longeveron

What analysts predicted

Upside of 407.14%

Current:

$1.75

Target:

$8.88

Insights on Longeveron

  • Price Movement

    In the last 1 year, LGVN stock has moved down by -87.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 468.0K → 773.0K (in $), with an average increase of 39.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -3.41M → -4.41M (in $), with an average decrease of 29.5% per quarter
  • LGVN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.3% return, outperforming this stock by 111.4%
  • LGVN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.1% return, outperforming this stock by 137.7%
  • Price to Sales

    ForLGVN every $1 of sales, investors are willing to pay $4.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.4 for every $1 of sales.

Longeveron Financials in INR & Dollars

FY18Y/Y Change
Revenue
$2.1M
-
Net Income
$-6.3M
-
Net Profit Margin
-296.84%
-
FY19Y/Y Change
Revenue
$5.6M
↑ 164.17%
Net Income
$-3.0M
↓ 52.73%
Net Profit Margin
-53.12%
↑ 243.72%
FY20Y/Y Change
Revenue
$5.6M
↓ 0.18%
Net Income
$-3.8M
↑ 26.56%
Net Profit Margin
-67.35%
↓ 14.23%
FY21Y/Y Change
Revenue
$1.3M
↓ 76.8%
Net Income
$-17.2M
↑ 352.73%
Net Profit Margin
-1.3K%
↓ 1246.89%
FY22Y/Y Change
Revenue
$1.2M
↓ 6.43%
Net Income
$-19.6M
↑ 14.35%
Net Profit Margin
-1.6K%
↓ 291.9%
FY23Y/Y Change
Revenue
$709.0K
↓ 41.98%
Net Income
$-21.4M
↑ 9.1%
Net Profit Margin
-3.0K%
↓ 1414.03%
Q2 FY23Q/Q Change
Revenue
$217.0K
↓ 22.22%
Net Income
$-5.6M
↑ 23.02%
Net Profit Margin
-2.6K%
↓ 954.53%
Q3 FY23Q/Q Change
Revenue
$150.0K
↓ 30.88%
Net Income
$-5.9M
↑ 4.83%
Net Profit Margin
-3.9K%
↓ 1340.61%
Q4 FY23Q/Q Change
Revenue
$63.0K
↓ 58.0%
Net Income
$-6.0M
↑ 2.1%
Net Profit Margin
-9.6K%
↓ 5632.25%
Q1 FY24Q/Q Change
Revenue
$548.0K
↑ 769.84%
Net Income
$-4.1M
↓ 32.68%
Net Profit Margin
-740.51%
↑ 8827.74%
Q2 FY24Q/Q Change
Revenue
$468.0K
↓ 14.6%
Net Income
$-3.4M
↓ 15.89%
Net Profit Margin
-729.27%
↑ 11.24%
Q3 FY24Q/Q Change
Revenue
$773.0K
↑ 65.17%
Net Income
$-4.4M
↑ 29.48%
Net Profit Margin
-571.67%
↑ 157.6%
FY18Y/Y Change
Profit
$680.6K
-
FY19Y/Y Change
Profit
$1.8M
↑ 157.71%
FY20Y/Y Change
Profit
$1.8M
↑ 4.12%
FY21Y/Y Change
Profit
$590.0K
↓ 67.69%
FY22Y/Y Change
Profit
$497.0K
↓ 15.76%
FY23Y/Y Change
Profit
$221.0K
↓ 55.53%
Q2 FY23Q/Q Change
Profit
$93.0K
↑ 22.37%
Q3 FY23Q/Q Change
Profit
$54.0K
↓ 41.94%
Q4 FY23Q/Q Change
Profit
$-238.0K
↓ 540.74%
Q1 FY24Q/Q Change
Profit
$76.0K
↓ 131.93%
Q2 FY24Q/Q Change
Profit
$344.0K
↑ 352.63%
Q3 FY24Q/Q Change
Profit
$682.0K
↑ 98.26%
FY18Y/Y Change
Operating Cash Flow
$-5.2M
-
Investing Cash Flow
$-211.7K
-
Financing Cash Flow
$1.4M
-
FY19Y/Y Change
Operating Cash Flow
$-2.4M
↓ 53.83%
Investing Cash Flow
$-125.0K
↓ 40.93%
Financing Cash Flow
$350.0K
↓ 74.17%
FY20Y/Y Change
Operating Cash Flow
$-2.4M
↓ 1.13%
Investing Cash Flow
$-261.5K
↑ 109.12%
Financing Cash Flow
$1.6M
↑ 350.09%
FY21Y/Y Change
Operating Cash Flow
$-9.6M
↑ 307.63%
Investing Cash Flow
$-10.7M
↑ 3990.25%
Financing Cash Flow
$45.2M
↑ 2767.59%
FY22Y/Y Change
Operating Cash Flow
$-14.0M
↑ 44.97%
Investing Cash Flow
$-677.0K
↓ 93.67%
Financing Cash Flow
$-509.0K
↓ 101.13%
Q2 FY23Q/Q Change
Operating Cash Flow
$-4.6M
↓ 21.32%
Investing Cash Flow
$2.5M
↑ 608.09%
Financing Cash Flow
$-86.0K
↑ 405.88%

Longeveron Technicals Summary

Sell

Neutral

Buy

Longeveron is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Longeveron Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Longeveron Inc
-15.05%
11.46%
-86.74%
-98.55%
-97.64%
Regeneron Pharmaceuticals, Inc.
-6.55%
-32.6%
-21.28%
12.81%
90.81%
Biontech Se
-2.77%
44.55%
1.43%
-55.8%
195.97%
Alnylam Pharmaceuticals, Inc.
-5.94%
-2.2%
22.08%
40.33%
105.82%
Vertex Pharmaceuticals Incorporated
-12.23%
-13.26%
-0.52%
86.14%
86.27%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Longeveron Inc
NA
NA
NA
0.0
-1.42
-0.62
NA
2.69
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.07
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Longeveron Inc
Buy
$27.3M
-97.64%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
90.81%
17.67
33.61%
Biontech Se
Buy
$27.3B
195.97%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.3B
105.82%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.8B
86.27%
32.84
-4.51%

About Longeveron

longeveron llc is a leading global regenerative medicine company developing innovative cellular therapeutics for chronic life-threatening diseases. our lead investigational product candidate (lmsc) is based on a specialized cell known as a mesenchymal stem cell that is derived from the bone marrow of healthy young adult donors. our allogeneic, ‘off-the-shelf’ product is under investigation for chronic conditions of the elderly, and other life- threatening diseases, for which no approved therapeutics currently exist: • aging frailty syndrome • alzheimer’s disease • hypoplastic left heart syndrome • the metabolic syndrome
Organization
Longeveron
Employees
23
CEO
Dr. Joshua Michael Hare FACC, M.D.
Industry
Miscellaneous

Management People of Longeveron

NameTitle
Dr. Joshua Michael Hare FACC, M.D.
Co-Founder, Chief Science Officer & Chairman
Mr. Mohamed Wa'el Ahmed Hashad M.B.A.
CEO & Director
Ms. Lisa A. Locklear M.B.A.
CFO & Treasurer
Mr. Paul T. Lehr J.D.
International Executive Director, General Counsel & Secretary
Dr. Dan Gincel Ph.D.
Senior Vice President of Strategic Collaborations & Scientific Affairs
Dr. Nataliya Agafonova M.D.
Chief Medical Officer
Ms. Lisa McClain-Moss
Vice President of Manufacturing
Mr. Brian G Rash Ph.D.
VP of Research & Discovery
Ms. Elly Ryu
VP & Corporate Controller
Mr. Michael Mannarino
VP & Corporate Controller

Important FAQs about investing in Longeveron from India :

What is Longeveron share price today?

Longeveron share price today stands at $1.75, Open: $1.80 ; Previous Close: $1.84 ; High: $1.84 ; Low: $1.71 ; 52 Week High: $14.30 ; 52 Week Low: $0.77. The stock opens at $1.80, after a previous close of $1.84. The stock reached a daily high of $1.84 and a low of $1.71, with a 52-week high of $14.30 and a 52-week low of $0.77.

Can Indians buy Longeveron shares?

Yes, Indians can invest in the Longeveron (LGVN) from India.

With INDmoney, you can buy Longeveron at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Longeveron at zero transaction cost.

How can I buy Longeveron shares from India?

It is very easy to buy Longeveron from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Longeveron be purchased?

Yes, you can buy fractional shares of Longeveron with INDmoney app.

What are the documents required to start investing in Longeveron stocks?

To start investing in Longeveron, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Longeveron

Today’s highest price of Longeveron (LGVN) is $1.84.

Today’s lowest price of Longeveron (LGVN) is $1.71.

What is today's market capitalisation of Longeveron

Today's market capitalisation of Longeveron LGVN is 27.3M

What is the 52 Week High and Low Range of Longeveron

  • 52 Week High

    $14.30

  • 52 Week Low

    $0.77

What are the historical returns of Longeveron?

  • 1 Month Returns

    -15.05%

  • 3 Months Returns

    11.46%

  • 1 Year Returns

    -86.74%

  • 5 Years Returns

    -97.64%

Who is the Chief Executive Officer (CEO) of Longeveron

Dr. Joshua Michael Hare FACC, M.D. is the current Chief Executive Officer (CEO) of Longeveron.